Monday, May 5, 2014

Brazil BSE Mad Cow disease confirmed OIE 02/05/2014

 

 

 From: Terry S. Singeltary Sr.

 

Sent: Monday, May 05, 2014 11:54 AM

 

To: BSE-L BSE-L

 

Cc: CJD-L ; CJDVOICE CJDVOICE ; bloodcjd bloodcjd

 

Subject: Brazil BSE Mad Cow disease confirmed OIE 02/05/2014

 

Bovine spongiform encephalopathy, Brazil

 

Information received on 02/05/2014 from Dr Figueiredo Marques Guilherme Henrique , Director, Departamento de Saúde Animal , Ministério da Agricultura, Pecuaria e Abastecimento , Brasilia, Brazil

 

Summary

 

Report type Immediate notification

 

Date of start of the event 19/03/2014

 

Date of pre-confirmation of the event 14/04/2014

 

Report date 02/05/2014

 

Date submitted to OIE 02/05/2014

 

Reason for notification Reoccurrence of a listed disease

 

Date of previous occurrence 19/12/2010

 

Manifestation of disease Sub-clinical infection

 

Causal agent Prion

 

Nature of diagnosis Laboratory (advanced)

 

This event pertains to the whole country

 

 New outbreaks (1)

 

 

 

Outbreak 1 Porto Esperidião, MATO GROSSO

 

Date of start of the outbreak 19/03/2014

 

Outbreak status Resolved (01/05/2014)

 

Epidemiological unit Farm

 

Affected animals

 

Species Susceptible Cases Deaths Destroyed Slaughtered

 

Cattle 1177 1 0 50 0

 

Buffaloes 11 0 0 0 0

 

Affected population A 12-year-old female bovine tested during emergency slaughter at the slaughterhouse. The animal was born and raised on a full-cycle beef farm on extensive grazing, with a population of 1,177 cattle and 11 buffaloes.

 

 Summary of outbreaks Total outbreaks: 1

 

Total animals affected

 

Species Susceptible Cases Deaths Destroyed Slaughtered

 

Cattle 1177 1 0 50 0

 

Buffaloes 11 0 0 0 0

 

Outbreak statistics

 

Species Apparent morbidity rate Apparent mortality rate Apparent case fatality rate Proportion susceptible animals lost*

 

Cattle 0.08% 0.00% 0.00% 4.25%

 

Buffaloes 0.00% 0.00% - 0.00%

 

*Removed from the susceptible population through death, destruction and/or slaughter

 

Epidemiology

 

Source of the outbreak(s) or origin of infection •Unknown or inconclusive

 

Epidemiological comments As part of the Brazilian surveillance system for Bovine Spongiform Encephalopathy (BSE), the prion marker was identified on 14 April 2014 in a 12-year-old female bovine sent for emergency slaughter because she was found fallen at her arrival at the slaughterhouse following some problems during transport. The animal was born and raised in the same full-cycle beef farm on extensive grazing. Meat and other products from this animal did not enter the food chain and there was no risk for human population. Tracing back animal movements since 2000, it was established that some animals from the birth cohort of this animal had been moved to 10 other properties in 3 municipalities in the state of Mato Grosso. During the epidemiological investigation, 49 animals from the cohort, which did not show clinical signs of the disease, were destroyed. Samples of nervous tissue were taken from the cohort animals and tested for BSE at the National Laboratory and all were negative on 1 May 2014. All control measures according to the OIE Terrestrial Animal Health Code have already been applied in order to close the outbreak and only the results of the typing tests carried out at the Reference Laboratory at Weybridge (United Kingdom) are pending.

 

Control measures

 

Measures applied •Quarantine •Screening •Modified stamping out •No vaccination •No treatment of affected animals

 

Measures to be applied •No other measures

 

Diagnostic test results

 

Laboratory name and type Species Test Test date Result

 

National Agricultural Laboratory (LANAGRO/PE) (National laboratory) Cattle immunohistochemical test 14/04/2014 Positive

 

National Agricultural Laboratory (LANAGRO/PE) (National laboratory) Cattle immunohistochemical test 01/05/2014 Negative

 

Animal Health and Veterinary Laboratories Agency (AHVLA), Weybridge, United Kingdom (OIE’s Reference Laboratory) Cattle immunohistochemical test 01/05/2014 Positive

 

Future Reporting

 

The event is continuing. Weekly follow-up reports will be submitted.

 

 Map of outbreak locations

 


 

 

>>>Atypical BSE, or “mad cow” disease, is a form of the prion disease not associated with the animal’s consumption of feed.<<<

 

 

don't you just love it when the officials just make stuff up $$$

 

 

*** What irks many scientists is the USDA’s April 25 statement that the rare disease is “not generally associated with an animal consuming infected feed.”

 

 

 The USDA’s conclusion is a “gross oversimplification,” said Dr. Paul Brown, one of the world’s experts on this type of disease who retired recently from the National Institutes of Health. "(The agency) has no foundation on which to base that statement.”

 

 


 

 

The present study demonstrated successful intraspecies transmission of H-type BSE to cattle and the distribution and immunolabeling patterns of PrPSc in the brain of the H-type BSE-challenged cattle. TSE agent virulence can be minimally defined by oral transmission of different TSE agents (C-type, L-type, and H-type BSE agents) [59]. Oral transmission studies with H-type BSE infected cattle have been initiated and are underway to provide information regarding the extent of similarity in the immunohistochemical and molecular features before and after transmission.

 

 

 In addition, the present data will support risk assessments in some peripheral tissues derived from cattle affected with H-type BSE.

 

 


 

 

 

 *** This supports the theory that the importation of BSE contaminated feedstuff is the source of C-type BSE in Canada.

 

 

 

 *** It also suggests a similar cause or source for atypical BSE in these countries. ***

 

 

 P.9.21

 

 

 Molecular characterization of BSE in Canada

 

 

 Jianmin Yang1, Sandor Dudas2, Catherine Graham2, Markus Czub3, Tim McAllister1, Stefanie Czub1 1Agriculture and Agri-Food Canada Research Centre, Canada; 2National and OIE BSE Reference Laboratory, Canada; 3University of Calgary, Canada

 

 

 Background: Three BSE types (classical and two atypical) have been identified on the basis of molecular characteristics of the misfolded protein associated with the disease. To date, each of these three types have been detected in Canadian cattle. Objectives: This study was conducted to further characterize the 16 Canadian BSE cases based on the biochemical properties of there associated PrPres.

 

 

 Methods: Immuno-reactivity, molecular weight, glycoform profiles and relative proteinase K sensitivity of the PrPres from each of the 16 confirmed Canadian BSE cases was determined using modified Western blot analysis.

 

 

 Results: Fourteen of the 16 Canadian BSE cases were C type, 1 was H type and 1 was L type. The Canadian H and L-type BSE cases exhibited size shifts and changes in glycosylation similar to other atypical BSE cases. PK digestion under mild and stringent conditions revealed a reduced protease resistance of the atypical cases compared to the C-type cases. N terminal- specific antibodies bound to PrPres from H type but not from C or L type. The C-terminal-specific antibodies resulted in a shift in the glycoform profile and detected a fourth band in the Canadian H-type BSE.

 

 

 Discussion: The C, L and H type BSE cases in Canada exhibit molecular characteristics similar to those described for classical and atypical BSE cases from Europe and Japan. *** This supports the theory that the importation of BSE contaminated feedstuff is the source of C-type BSE in Canada. *** It also suggests a similar cause or source for atypical BSE in these countries. ***

 

 

 see page 176 of 201 pages...tss

 

 


 

 

 Singeltary reply ; Molecular, Biochemical and Genetic Characteristics of BSE in Canada Singeltary reply ;

 


 

 

 P.4.23

 

 

 Transmission of atypical BSE in humanized mouse models

 

 Liuting Qing1, Wenquan Zou1, Cristina Casalone2, Martin Groschup3, Miroslaw Polak4, Maria Caramelli2, Pierluigi Gambetti1, Juergen Richt5, Qingzhong Kong1 1Case Western Reserve University, USA; 2Instituto Zooprofilattico Sperimentale, Italy; 3Friedrich-Loeffler-Institut, Germany; 4National Veterinary Research Institute, Poland; 5Kansas State University (Previously at USDA National Animal Disease Center), USA

 

 Background: Classical BSE is a world-wide prion disease in cattle, and the classical BSE strain (BSE-C) has led to over 200 cases of clinical human infection (variant CJD). Atypical BSE cases have been discovered in three continents since 2004; they include the L-type (also named BASE), the H-type, and the first reported case of naturally occurring BSE with mutated bovine PRNP (termed BSE-M). The public health risks posed by atypical BSE were largely undefined.

 

 Objectives: To investigate these atypical BSE types in terms of their transmissibility and phenotypes in humanized mice. Methods: Transgenic mice expressing human PrP were inoculated with several classical (C-type) and atypical (L-, H-, or Mtype) BSE isolates, and the transmission rate, incubation time, characteristics and distribution of PrPSc, symptoms, and histopathology were or will be examined and compared.

 

 Results: Sixty percent of BASE-inoculated humanized mice became infected with minimal spongiosis and an average incubation time of 20-22 months, whereas only one of the C-type BSE-inoculated mice developed prion disease after more than 2 years. Protease-resistant PrPSc in BASE-infected humanized Tg mouse brains was biochemically different from bovine BASE or sCJD. PrPSc was also detected in the spleen of 22% of BASE-infected humanized mice, but not in those infected with sCJD. Secondary transmission of BASE in the humanized mice led to a small reduction in incubation time.*** The atypical BSE-H strain is also transmissible with distinct phenotypes in the humanized mice, but no BSE-M transmission has been observed so far.

 

 Discussion: Our results demonstrate that BASE is more virulent than classical BSE, has a lymphotropic phenotype, and displays a modest transmission barrier in our humanized mice. BSE-H is also transmissible in our humanized Tg mice. The possibility of more than two atypical BSE strains will be discussed.

 

 Supported by NINDS NS052319, NIA AG14359, and NIH AI 77774.

 


 

 

 P26 TRANSMISSION OF ATYPICAL BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) IN HUMANIZED MOUSE MODELS

 

 

 Liuting Qing1, Fusong Chen1, Michael Payne1, Wenquan Zou1, Cristina Casalone2, Martin Groschup3, Miroslaw Polak4, Maria Caramelli2, Pierluigi Gambetti1, Juergen Richt5*, and Qingzhong Kong1 1Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA; 2CEA, Istituto Zooprofilattico Sperimentale, Italy; 3Friedrich-Loeffler-Institut, Germany; 4National Veterinary Research Institute, Poland; 5Kansas State University, Diagnostic Medicine/Pathobiology Department, Manhattan, KS 66506, USA. *Previous address: USDA National Animal Disease Center, Ames, IA 50010, USA

 

 Classical BSE is a world-wide prion disease in cattle, and the classical BSE strain (BSE-C) has led to over 200 cases of clinical human infection (variant CJD). Two atypical BSE strains, BSE-L (also named BASE) and BSE-H, have been discovered in three continents since 2004. The first case of naturally occurring BSE with mutated bovine PrP gene (termed BSE-M) was also found in 2006 in the USA. The transmissibility and phenotypes of these atypical BSE strains/isolates in humans were unknown. We have inoculated humanized transgenic mice with classical and atypical BSE strains (BSE-C, BSE-L, BSE-H) and the BSE-M isolate. We have found that the atypical BSE-L strain is much more virulent than the classical BSE-C. *** The atypical BSE-H strain is also transmissible in the humanized transgenic mice with distinct phenotype, but no transmission has been observed for the BSE-M isolate so far.

 

 III International Symposium on THE NEW PRION BIOLOGY: BASIC SCIENCE, DIAGNOSIS AND THERAPY 2 - 4 APRIL 2009, VENEZIA (ITALY)

 


 

 

 UPDATE

 

 I ask Professor Kong ; Thursday, December 04, 2008 3:37 PM

 

 Subject: RE: re--Chronic Wating Disease (CWD) and Bovine Spongiform Encephalopathies (BSE): Public Health Risk Assessment

 

 ''IS the h-BSE more virulent than typical BSE as well, or the same as cBSE, or less virulent than cBSE? just curious.....''

 

 Professor Kong reply ;

 

 .....snip

 

 ''As to the H-BSE, we do not have sufficient data to say one way or another, but we have found that H-BSE can infect humans. I hope we could publish these data once the study is complete. Thanks for your interest.''

 

 Best regards, Qingzhong Kong, PhD Associate Professor Department of Pathology Case Western Reserve University Cleveland, OH 44106 USA END...TSS

 

 

 Thursday, December 04, 2008 2:37 PM

 

 "we have found that H-BSE can infect humans."

 

 personal communication with Professor Kong. ...TSS

 

 BSE-H is also transmissible in our humanized Tg mice. The possibility of more than two atypical BSE strains will be discussed.

 

 Supported by NINDS NS052319, NIA AG14359, and NIH AI 77774.

 


 


 

 

 please see below from PRION2013 ;

 

 

 *** This study imply the possibility that the novel BSE prions with high virulence in cattle will be emerged during intraspecies transmission.

 

 AD.56: The emergence of novel BSE prions by serial passages of H-type BSE in bovinized mice

 

 Kentaro Masujin, Naoko Tabeta, Ritsuko Miwa, Kohtaro Miyazawa, Hiroyuki Okada, Shirou Mohri and Takashi Yokoyama National Institute of Animal Health; Tsukuba, Japan

 

 H-type bovine spongiform encephalopathy (BSE) is an atypical form of BSE, and has been detected in several European countries, and North America. Transmission studies of H-type BSE led to the emergence of the classical BSE (C-BSE) phenotypes during passages in inbred wild type and bovinized PrP-overexpressing transgenic mice. In this study, we conducted serial passages of Canadian H-type BSE isolate in bovinized PrP-overexpressing transgenic mice (TgBoPrP). H-type BSE isolate was transmitted to TgBoPrP with incubation periods of 320 ± 12.2 d at primary passage. The incubation period of 2nd and 3rd passage were constant (~= 220 d), no clear differences were observed in their biological and biochemical properties. However, at the forth passage, 2 different BSE phenotypes were confirmed; one is shorter survival times (109 ± 4 d) and the other is longer survival times. TgBoPrP mice with longer incubation period showed the H-type phenotype of PrPsc profile and pathology. However, those of shorter incubation period were different phenotypes from previously existed BSE prions (C-BSE, L-type BSE, and H-type BSE).

 

 *** This study imply the possibility that the novel BSE prions with high virulence in cattle will be emerged during intraspecies transmission.

 


 

 www.landesbioscience.com

 

 please see ;

 

 Thursday, August 15, 2013

 

 The emergence of novel BSE prions by serial passages of H-type BSE in bovinized mice

 


 

 

 LET'S take a closer look at this new prionpathy or prionopathy, and then let's look at the g-h-BSEalabama mad cow. This new prionopathy in humans? the genetic makeup is IDENTICAL to the g-h-BSEalabama mad cow, the only _documented_ mad cow in the world to date like this, ......wait, it get's better. this new prionpathy is killing young and old humans, with LONG DURATION from onset of symptoms to death, and the symptoms are very similar to nvCJD victims, OH, and the plaques are very similar in some cases too, bbbut, it's not related to the g-h-BSEalabama cow, WAIT NOW, it gets even better, the new human prionpathy that they claim is a genetic TSE, has no relation to any gene mutation in that family. daaa, ya think it could be related to that mad cow with the same genetic make-up ??? there were literally tons and tons of banned mad cow protein in Alabama in commerce, and none of it transmitted to cows, and the cows to humans there from ??? r i g h t $$$ ALABAMA MAD COW g-h-BSEalabama In this study, we identified a novel mutation in the bovine prion protein gene (Prnp), called E211K, of a confirmed BSE positive cow from Alabama, United States of America. This mutation is identical to the E200K pathogenic mutation found in humans with a genetic form of CJD. This finding represents the first report of a confirmed case of BSE with a potential pathogenic mutation within the bovine Prnp gene. We hypothesize that the bovine Prnp E211K mutation most likely has caused BSE in "the approximately 10-year-old cow" carrying the E221K mutation.

 


 

 


 

 

 Saturday, August 14, 2010

 

 BSE Case Associated with Prion Protein Gene Mutation (g-h-BSEalabama) and VPSPr PRIONPATHY (see mad cow feed in COMMERCE IN ALABAMA...TSS)

 


 

 

 her healthy calf also carried the mutation (J. A. Richt and S. M. Hall PLoS Pathog. 4, e1000156; 2008).

 

 This raises the possibility that the disease could occasionally be genetic in origin. Indeed, the report of the UK BSE Inquiry in 2000 suggested that the UK epidemic had most likely originated from such a mutation and argued against the scrapierelated assumption. Such rare potential pathogenic PRNP mutations could occur in countries at present considered to be free of BSE, such as Australia and New Zealand. So it is important to maintain strict surveillance for BSE in cattle, with rigorous enforcement of the ruminant feed ban (many countries still feed ruminant proteins to pigs). Removal of specified risk material, such as brain and spinal cord, from cattle at slaughter prevents infected material from entering the human food chain. Routine genetic screening of cattle for PRNP mutations, which is now available, could provide additional data on the risk to the public. Because the point mutation identified in the Alabama animals is identical to that responsible for the commonest type of familial (genetic) CJD in humans, it is possible that the resulting infective prion protein might cross the bovine-human species barrier more easily. Patients with vCJD continue to be identified. The fact that this is happening less often should not lead to relaxation of the controls necessary to prevent future outbreaks. Malcolm A. Ferguson-Smith Cambridge University Department of Veterinary Medicine, Madingley Road, Cambridge CB3 0ES, UK e-mail: maf12@cam.ac.uk Jürgen A. Richt College of Veterinary Medicine, Kansas State University, K224B Mosier Hall, Manhattan, Kansas 66506-5601, USA NATURE|Vol 457|26 February 2009

 


 

 

 P.9.21 Molecular characterization of BSE in Canada

 

 Jianmin Yang1, Sandor Dudas2, Catherine Graham2, Markus Czub3, Tim McAllister1, Stefanie Czub1 1Agriculture and Agri-Food Canada Research Centre, Canada; 2National and OIE BSE Reference Laboratory, Canada; 3University of Calgary, Canada

 

 Background: Three BSE types (classical and two atypical) have been identified on the basis of molecular characteristics of the misfolded protein associated with the disease. To date, each of these three types have been detected in Canadian cattle.

 

 Objectives: This study was conducted to further characterize the 16 Canadian BSE cases based on the biochemical properties of there associated PrPres.

 

 Methods: Immuno-reactivity, molecular weight, glycoform profiles and relative proteinase K sensitivity of the PrPres from each of the 16 confirmed Canadian BSE cases was determined using modified Western blot analysis. Results: Fourteen of the 16 Canadian BSE cases were C type, 1 was H type and 1 was L type. The Canadian H and L-type BSE cases exhibited size shifts and changes in glycosylation similar to other atypical BSE cases. PK digestion under mild and stringent conditions revealed a reduced protease resistance of the atypical cases compared to the C-type cases. N terminal- specific antibodies bound to PrPres from H type but not from C or L type. The C-terminal-specific antibodies resulted in a shift in the glycoform profile and detected a fourth band in the Canadian H-type BSE.

 

 Discussion: The C, L and H type BSE cases in Canada exhibit molecular characteristics similar to those described for classical and atypical BSE cases from Europe and Japan. This supports the theory that the importation of BSE contaminated feedstuff is the source of C-type BSE in Canada. *** It also suggests a similar cause or source for atypical BSE in these countries.

 


 

 

 Saturday, August 14, 2010

 

 ***BSE Case Associated with Prion Protein Gene Mutation (g-h-BSEalabama) and VPSPr PRIONPATHY

 

 *** (see mad cow feed in COMMERCE IN ALABAMA...TSS)

 


 

 

 Sunday, December 15, 2013

 

 FDA PART 589 -- SUBSTANCES PROHIBITED FROM USE IN ANIMAL FOOD OR FEED VIOLATIONS OFFICIAL ACTION INDICATED OIA UPDATE DECEMBER 2013 UPDATE

 


 

 

 kind regards, terry

 

 

UPDATE SEE R-CALF CONCERNS

 

 Brazil's Second Reported BSE Case Raises Food Safety Concerns

 

 Billings, Mont. - On Monday the World Organization for Animal Health (OIE) provided notice that Brazil confirmed its second case of bovine spongiform encephalopathy (BSE), this time in a 12-year-old Brazilian cow. While the notice states that none of the meat or other products from the infected cow entered the food chain, a recent audit report by the U.S. Department of Agriculture (USDA) reveals that Brazil has not been complying with BSE safeguard measures required by the United States.

 

 A recent audit report

 


 

 

 by the USDA Food Safety and Inspection Service (FSIS) sent to the Brazilian government on April 16, 2014, reveals that Brazil has not been consistently implementing the United States' mandatory requirement that all specified risk materials (SRMs) from cattle be excluded from the human food chain as a condition for allowing Brazil to export beef to the United States.

 

 Specifically, the audit found that beginning in early 2007, the Brazilian government relaxed its SRM removal policies by issuing a notice that removed the skull, trigeminal ganglia, vertebral column, and dorsal root ganglia in cattle 30 months of age or older from the list of SRMs that must be removed at slaughter. The tissues improperly removed from the list of SRMs by the Brazilian government are tissues known to harbor the BSE agent in infected cattle.

 

 United States food safety inspectors confirmed that Brazil was not routinely removing all high-risk tissues as required for countries that export to the United States.

 

 Despite Brazil's failure to meet U.S. food safety standards, FSIS officials nevertheless determined that Brazil "continues to meet FSIS equivalence criteria at an adequate level for this component (the SRM removal component)."

 

 R-CALF USA CEO Bill Bullard said these facts demonstrate the need to fully enforce the U.S. country-of-origin labeling (COOL) law. "Only with COOL can consumers choose to avoid purchasing their food from countries with questionable food safety systems," he said.

 

 Bullard also said these facts along with USDA's current plan to begin importing beef from Brazilian states that are not free of foot-and-mouth disease (FMD) is deeply troubling.

 

 "More and more the USDA is demonstrating its unwillingness to prioritize food safety and animal health above its politically motivated trade relations goals," he concluded.

 

 # # #

 

 R-CALF USA (Ranchers-Cattlemen Action Legal Fund, United Stockgrowers of America) is the largest producer-only cattle trade association in the United States. It is a national, nonprofit organization dedicated to ensuring the continued profitability and viability of the U.S. cattle industry. For more information, visit www.r-calfusa.com or, call 406-252-2516.

 

 

Thursday, April 24, 2014

 

Brazil investigates possible BSE mad cow case

 


 

 

Thursday, September 26, 2013

 

Brazil evaluate the implementation of health rules on animal by-products and derived products SRM BST TSE PRION aka MAD COW DISEASE

 


 

 

Friday, December 07, 2012

 

ATYPICAL BSE BRAZIL 2010 FINALLY CONFIRMED OIE 2012

 


 

 

Wednesday, December 19, 2012

 

Scientific Report of the European Food Safety Authority on the Assessment of the Geographical BSE Risk (GBR) of Brazil

 


 

 

 

 

TSS

Thursday, April 24, 2014

Brazil investigates possible BSE mad cow case

Brazil investigates possible BSE case

 

 

Reuters | Updated: 04/24/2014

 

 

 

Brazil is investigating a potential case of atypical mad cow disease, the agriculture ministry said on Thursday, just over a year after several countries banned Brazilian beef imports when a similar case of the disease was confirmed.

 

A routine inspection at a slaughterhouse in Mato Grosso state found an animal that veterinarians suspect of having a neurological problems, a ministry spokesman said in an e-mail.

 

Laboratory tests are under way and atypical bovine spongiform encephalopathy (BSE), or mad cow disease, has not yet been confirmed, the e-mail said.

 

In late 2012 tests showed that a cow that died two years earlier in Parana state had developed the protein that causes BSE, though the animal never developed the disease and died of natural causes.

 

The case was considered "atypical" as the animal contracted the protein spontaneously, rather than through the feed supply. Classical cases of BSE are caused when cattle are fed brain or spinal tissue of other ruminants, which is now forbidden in nearly all beef producing countries including Brazil.

 

The World Animal Health Organization maintained Brazil's status as a country with an insignificant risk of BSE after it confirmed the atypical Parana case in tests carried out in England in 2012.

 

Even so, several countries including South Korea, China and Egypt banned some or all beef imports from Brazil, the world's top exporter.

 

Humans can develop what is known as variant Creutzfeldt-Jakob disease from consuming animals with mad cow, and more than 150 people have died from it. Mad cow was first discovered in Britain in 1986, but strict controls have tempered its spread.

 

 




 
24/04/2014 14:59Defesa sanitária

Mapa investiga caso atípico de EEB


O Ministério da Agricultura, Pecuária e Abastecimento (Mapa) acionou o sistema de defesa animal para averiguar um caso provável de Encefalopatia Espongiforme Bovina (EEB), no estado de Mato Grosso. As investigações de campo indicam tratar-se de uma única suspeita de caso atípico de EEB, já que o animal foi criado exclusivamente em sistema extensivo (a pasto e sal mineral) e foi abatido em idade avançada, com cerca de12 anos de idade. Essas são as principais características de um caso atípico de EEB, pois ocorre de forma esporádica e espontânea, não relacionada à ingestão de alimentos contaminados.
Os produtos derivados desse bovino não ingressaram na cadeia de alimentação humana ou animal e o material de risco foi incinerado. Por precaução, todos os animais contemporâneos ao caso provável foram identificados individualmente e interditados.
O bovino analisado foi enviado para abate no dia 19 de março de 2014, em virtude de problemas reprodutivos ocasionados pela idade avançada e sem sintomas de distúrbios neurológicos. Durante a inspeção ante mortem, o fiscal federal agropecuário responsável pela fiscalização no frigorífico observou que havia um animal caído, ou seja, em “decúbito forçado”. Com esse quadro, o animal não foi considerado apto ao abate de rotina, sendo direcionado ao abate de emergência e submetido à colheita de amostras para o teste de EEB.
O resultado final dos exames realizados em laboratório nacional agropecuário detectou a marcação priônica. Conforme os protocolos brasileiros, foram deflagradas atividades imediatas no sentido de realizar investigação epidemiológica a campo e providências para o envio da amostra ao laboratório de referência internacional da Organização Mundial de Saúde Animal (OIE), em Weybridge, na Inglaterra, para confirmação da suspeita.
O sistema de defesa sanitária animal brasileiro relacionado à EEB já está consolidado há décadas e permitiu ao Brasil ser classificado como país com risco insignificante para a doença perante a OIE. Essa classificação é a melhor que existe no mundo. Todas as informações sobre o caso já foram repassadas pessoalmente por representantes do Mapa à OIE, que enalteceu a transparência e competência brasileira, colocando inclusive sua estrutura à disposição, assim como seus laboratórios de referência.
A notificação oficial e novas informações sobre o caso serão repassadas quando sair o resultado final da avaliação do laboratório da OIE, na próxima semana.


Palavras chave: caso atípico EEB Mapa



http://www.agricultura.gov.br/comunicacao/noticias/2014/04/mapa-investiga-caso-atipico-de-eeb

 

Friday, December 07, 2012

 

ATYPICAL BSE BRAZIL 2010 FINALLY CONFIRMED OIE 2012

 


 

 

Wednesday, December 19, 2012

 

Scientific Report of the European Food Safety Authority on the Assessment of the Geographical BSE Risk (GBR) of Brazil

 


 

 

Wednesday, February 12, 2014

 

USDA/APHIS NOTICE: Final Rule Regarding Imports and BSE Effective March 4, 2014

 


 

 

Friday, March 21, 2014

 

Rancho Dead Stock Cancer Downers Recall Explained FSIS March 20 2014 ?

 

“As of March 20, 2014, FSIS has completed all checks (effectiveness checks and disposition verification checks) for recalls 002-2014 and 013-2014 regarding Rancho Feeding Corporation. FSIS has determined that based on the number of successful checks (see Directive 8080.1, Attachment 1, Table 3) where businesses were notified of the recall and removed affected products from commerce that the recall activities were effective.”

 


 

 

Friday, April 4, 2014

 

China, Australia, Argentina, Brazil, Uruguay, Morocco, Israel, South Africa and Saudi Arabia still retain BSE-related closures

 


 

 

Tuesday, July 17, 2012

 

O.I.E. BSE, CWD, SCRAPIE, TSE PRION DISEASE Final Report of the 80th General Session, 20 - 25 May 2012

 


 

 

Saturday, April 19, 2014

 

*** Exploring the zoonotic potential of animal prion diseases: In vivo and in vitro approaches ***

 


 

 

 

TSS

Saturday, April 19, 2014

Estimation of the Exposure of the UK Population to the Bovine Spongiform Encephalopathy Agent through Dietary Intake During the Period 1980 to 1996

Estimation of the Exposure of the UK Population to the Bovine Spongiform Encephalopathy Agent through Dietary Intake During the Period 1980 to 1996

 

Chu-Chih Chen mail,

 

Yin-Han Wang

 

Published: April 15, 2014 •DOI: 10.1371/journal.pone.0094020

 

Abstract

 

Although the incidence of variant Creutzfeldt-Jakob disease (vCJD) has declined to 1 since 2012 in the UK, uncertainty remains regarding possible future cases and the size of the subclinical population that may cause secondary transmission of the disease through blood transfusion. Estimating the number of individuals who were exposed to the bovine spongiform encephalopathy (BSE) infectious agent and may be susceptible to vCJD will help to clarify related public health concerns and plan strategies. In this paper, we explore this estimate by describing the probability of potential exposure due to dietary intake throughout the BSE epidemic period from 1980 to 1996 as a stochastic Poisson process. We estimate the age- and gender-specific exposure intensities in food categories of beef and beef-containing dishes, burgers and kebabs, pies, and sausages, separating the two periods of 1980–1989 and 1990–1996 due to the specified bovine offal legislation of 1989. The estimated total number of (living) exposed individuals during each period is 5,089,027 (95% confidence interval [CI] 4,514,963–6,410,317), which was obtained by multiplying the population size of different birth cohorts by the probability of exposure via dietary intake and the probability of survival until the end of 2013. The estimated number is approximately doubled, assuming a contamination rate of . Among those individuals estimated, 31,855 (95% CI 26,849–42,541) are susceptible to infection. We also examined the threshold hypothesis by fitting an extreme-value distribution to the estimated infectious dose of the exposed individuals and obtained a threshold estimate of 13.7 bID50 (95% CI 6.6–26.2 bID50) (Weibull). The results provide useful information on potential carriers of prion disease who may pose a threat of infection via blood transfusion and thus provide insight into the likelihood of new incidents of vCJD occurring in the future.

 

snip...

 

Discussion

 

In this study, we estimated the number of exposed individuals in the UK during the BSE epidemic period 1980–1996 based on the estimated BSE-infected cattle in the last year of incubation and unreported or differentially slaughtered for consumption [15], [17], [42], the average age-specific bovine meat intake [28]–[32], and the national statistics [40]. We then estimated the numbers of subclinical carriers of abnormal prion for different genotypes at PRNP codon 129 after being exposed from the posterior susceptibility estimate with prior information obtained from the literature [13], [17]. We describe the probability of being exposed via dietary intake through the entire period by a stochastic Poisson process. This approach requires only an estimation of the mean exposure intensity of the infectious agent in bovine meat products. Thus, the assumption of the incubation period distribution and time of infection based on the observed vCJD cases, as in the back-calculation method [15]–[23] and other simulation-based approaches [24]–[27], is avoided, which significantly reduces estimation uncertainty. Furthermore, the possibility of repeated exposure [41] and the data concerning age-specific bovine meat consumption [28]–[32] are naturally taken into account in the estimation procedure. Therefore, the results provide important estimates of the prevalence of subclinical infection from mathematical modeling, in addition to the scale of exposure of the UK population to the BSE infectious agent, which cannot be derived simply from the observed vCJD cases.

 

Observed cases of vCJD occurring via the primary infection route of bovine meat consumption remain very small in recent years [1], as does prediction for future incidents [2]. However, uncertainty regarding the secondary infection route – blood transfusion from asymptomatic infected donors – has raised great concerns for public health and related administration strategies [3]–[7]. The estimate of approximately 32,000 exposed individuals who are potential subclinical carriers of abnormal prions provides a more concise estimate and is consistent with the results obtained from several large-scale biomarker studies on infection prevalence in the UK [5]–[13]. We obtained our estimates mainly based on the survey outcomes of Gill et al. [13], especially for the MV and VV genotypes, because previous surveys did not provide prevalence information on age and genotype [9]–[11]. Also, the infection function given by Valleron et al. [17] is for the MM genotype only. The approximately the same scale across different age groups essentially shows that both the susceptibility estimate of Valleron et al. [17] and the survey outcomes of Gill et al. [13] are reflected in the posterior estimate. A similar explanation applies to estimates for the MV and VV genotypes. These carriers are most likely subclinical to vCJD without developing into a case if they were exposed to a relatively low infectious dose. However, for the null prevalence of certain age categories and the 1990–1996 birth cohort (mainly from Valleron et al. [17]), the numbers may change substantially if positive sample(s) were detected for these categories in future surveys.

 

We have further justified the threshold hypothesis [4], [34]–[39] and provided an explicit threshold estimate of the infectious dose by fitting an extreme-value distribution model to the estimated number of exposed individuals and comparing that with the number of vCJD cases in each birth cohort. The existence of a threshold dose for infection has been conjectured and assessed in the literature [4], [36]–[39]. Based on the dose-response curve observed in mice, Fryer and McLean conclude that there is no evidence of the existence of such a threshold [38]. However, if this were the case in humans, the number of vCJD cases would have been far more than what has been observed to date, given our exposed individual estimate and the exponential growth rate of abnormal prions in the brain once infected [35]. The close model fitting to the observed vCJD cases justifies the threshold hypothesis. Furthermore, the threshold dose estimate of approximately 12 bID50 with an equivalent weight of 1.2 g of a BSE-infected bovine brain [39] also appears reasonable, which may alternatively be interpreted as the species barrier between bovine and human [39], [50].

 

The estimated number of exposed individuals is based on the estimation of the BSE-infected bovines in the last year of incubation and unreported or differentially slaughtered for consumption during the 1980–1996 period [16]. The figure could be much higher if all of the pre-clinical bovines and contaminated meat products made from beef that entered the food chain are considered when deriving the exposure intensity. Also, we exclude trigeminal ganglia, ileum, tonsil, spleen and eyes in our estimate of contaminated MRM because these parts are typically removed before meat consumption. However, bovine intestine was used for the manufacture of natural sausage casings prior to the SBO ban in 1989 [42]. Therefore, it is possible that individuals might be exposed through consumption of sausages with castings from contaminated intestine, which may substantially increase the number of exposed individuals. Because of the thinness, the infectivity in casings (if there is any) would be very low compared to that in contaminated MRM and head meat. Offals such as rectums and small intestines are also reported being exported to Germany for sausage manufacture and casings [45]. Based on these considerations, we choose to ignore the number of exposed individuals through this route. We rule out the possibility of being exposed by consumption of brain from preclinical BSE bovine directly, given that the major sources entering the food chain in the period were MRM and head meat [45] and none of the vCJD cases have reported eating bovine brain [42].

 

We adopt a Bayesian simulation approach to handle the great uncertainties in the proportions of MRM and head meat used in producing beef and beef-containing dishes, burgers and kebabs, pies, and sausages that might have contained BSE infectious agents during the 1980–1996 period. The results show that although the simulated 95% CIs cover a wide range, the estimated numbers are of approximately the same scale. Also, although the excess numbers of estimated individuals exposed due to ingestion of contaminated meat are very large, the amount of the exposure dose may be negligible for most people, except for the subclinical carriers who might be exposed to a certain amount of infectivity. As shown in Table 4, the numbers of possibly exposed individuals and subclinical carriers increase substantially with a CR of . However, the threshold dose estimate remains approximately the same when the mean exposure dose decreases to about a quarter of that given in the scenario of CR = 0. Therefore, the future vCJD prediction is not expected to change because of exposure uncertainty.

 

In summary, the estimated current numbers of exposed individuals and those who are susceptible or carry the vCJD infectious agent may provide necessary information regarding the extent of the potential public health threat in the tail of the vCJD epidemic in the UK. The number of susceptible exposed individuals is especially important for assessing the risk of secondary transmission via blood transfusion, plasma products, or contaminated surgical instruments; assessment of this risk has been inconclusive or inconsistent based on the results of several large-scale biomarker studies [5]–[14]. Furthermore, the almost exact match between the predicted and observed vCJD cases and the threshold infectious dose estimate has greatly reduced the uncertainty regarding future incidents via the primary transmission route, food intake. However, the results obtained cannot infer the likelihood of secondary transmission from the asymptotic carriers of prion disease.

 

see full text ;

 


 

CJD and Baby foods (the great debate 1999)

 

Subject: Re: Girl, 13, shows CJD symptoms.

 

From: "Terry S. Singeltary Sr."

 

Reply-To: Bovine Spongiform Encephalopathy

 

Date: Wed, 24 Nov 1999 11:35:44 -0600 Content-Type: text/plain Parts/Attachments: text/plain (67 lines)

 


 

Sunday, May 18, 2008

 

MAD COW DISEASE BSE CJD CHILDREN VACCINES

 


 

 Sunday, May 18, 2008

 

BSE Inquiry DRAFT FACTUAL ACCOUNTS DFAs

 


 

 Monday, May 19, 2008

 

*** SPORADIC CJD IN FARMERS, FARMERS WIVES, FROM FARMS WITH BSE HERD AND ABATTOIRS ***

 


 

“Cases of vCJD peaked in 2000, leading some scientists to speculate that the disease has an incubation period of about a decade. Yet studies of different forms of CJD suggest that the incubation time of vCJD could be much longer, indicating that many people in Britain could be carrying the infection without symptoms.”

 


 

Monday, October 14, 2013

 

Researchers estimate one in 2,000 people in the UK carry variant CJD proteins

 


 

However, I think that the specific confusion there is that people talk about sporadic CJD occurring at 1 per million. That is not your individual risk. Your risk is 1 per million every year. Actually, it is nearer 2 per million per year of the population will develop sporadic CJD, but your lifetime risk of developing sporadic CJD is about 1 in 30,000. So that has not really changed. When people talk about 1 per million, often they interpret that as thinking it is incredibly rare. They think they have a 1-in-a-million chance of developing this disease. You haven’t. You’ve got about a 1-in-30,000 chance of developing it.

 


 

Cases of vCJD peaked in 2000, leading some scientists to speculate that the disease has an incubation period of about a decade. Yet studies of different forms of CJD suggest that the incubation time of vCJD could be much longer, indicating that many people in Britain could be carrying the infection without symptoms.

 


 

Friday, February 14, 2014

 

Creutzfeldt-Jakob disease (CJD) biannual update (February 2014), with briefing on novel human prion disease National CJD Research and Surveillance Unit NCJDRSU

 


 

Wednesday, December 11, 2013

 

*** Detection of Infectivity in Blood of Persons with Variant and Sporadic Creutzfeldt-Jakob Disease ***

 


 

To date the OIE/WAHO assumes that the human and animal health standards set out in the BSE chapter for classical BSE (C-Type) applies to all forms of BSE which include the H-type and L-type atypical forms. This assumption is scientifically not completely justified and accumulating evidence suggests that this may in fact not be the case. Molecular characterization and the spatial distribution pattern of histopathologic lesions and immunohistochemistry (IHC) signals are used to identify and characterize atypical BSE. Both the L-type and H-type atypical cases display significant differences in the conformation and spatial accumulation of the disease associated prion protein (PrPSc) in brains of afflicted cattle. Transmission studies in bovine transgenic and wild type mouse models support that the atypical BSE types might be unique strains because they have different incubation times and lesion profiles when compared to C-type BSE. When L-type BSE was inoculated into ovine transgenic mice and Syrian hamster the resulting molecular fingerprint had changed, either in the first or a subsequent passage, from L-type into C-type BSE. ***In addition, non-human primates are specifically susceptible for atypical BSE as demonstrated by an approximately 50% shortened incubation time for L-type BSE as compared to C-type. Considering the current scientific information available, it cannot be assumed that these different BSE types pose the same human health risks as C-type BSE or that these risks are mitigated by the same protective measures.

 


 

Thursday, August 12, 2010

 

Seven main threats for the future linked to prions

 

First threat

 

The TSE road map defining the evolution of European policy for protection against prion diseases is based on a certain numbers of hypotheses some of which may turn out to be erroneous. In particular, a form of BSE (called atypical Bovine Spongiform Encephalopathy), recently identified by systematic testing in aged cattle without clinical signs, may be the origin of classical BSE and thus potentially constitute a reservoir, which may be impossible to eradicate if a sporadic origin is confirmed.

 

***Also, a link is suspected between atypical BSE and some apparently sporadic cases of Creutzfeldt-Jakob disease in humans. These atypical BSE cases constitute an unforeseen first threat that could sharply modify the European approach to prion diseases.

 

Second threat

 

snip...

 


 

BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein

 

Variant Creutzfeldt–Jakob disease (vCJD) has been recognized to date only in individuals homozygous for methionine at PRNP codon 129. Here we show that transgenic mice expressing human PrP methionine 129, inoculated with either bovine spongiform encephalopathy (BSE) or variant CJD prions, may develop the neuropathological and molecular phenotype of vCJD, consistent with these diseases being caused by the same prion strain. Surprisingly, however, BSE transmission to these transgenic mice, in addition to producing a vCJD-like phenotype, can also result in a distinct molecular phenotype that is indistinguishable from that of sporadic CJD with PrPSc type 2. These data suggest that more than one BSE-derived prion strain might infect humans; it is therefore possible that some patients with a phenotype consistent with sporadic CJD may have a disease arising from BSE exposure.

 


 

-------- Original Message --------

 

Subject: re-BSE prions propagate as either variant CJD-like or sporadic CJD

 

Date: Thu, 28 Nov 2002 10:23:43 -0000

 

From: "Asante, Emmanuel A" e.asante@ic.ac.uk

 

To: "'flounder@wt.net'" flounder@wt.net

 

Dear Terry,

 

I have been asked by Professor Collinge to respond to your request. I am a Senior Scientist in the MRC Prion Unit and the lead author on the paper. I have attached a pdf copy of the paper for your attention.

 

Thank you for your interest in the paper.

 

In respect of your first question, the simple answer is, yes. As you will find in the paper, we have managed to associate the alternate phenotype to type 2 PrPSc, the commonest sporadic CJD. It is too early to be able to claim any further sub-classification in respect of Heidenhain variant CJD or Vicky Rimmer's version. It will take further studies, which are on-going, to establish if there are sub-types to our initial finding which we are now reporting. The main point of the paper is that, as well as leading to the expected new variant CJD phenotype, BSE transmission to the 129-methionine genotype can lead to an alternate phenotype which is indistinguishable from type 2 PrPSc.

 

I hope reading the paper will enlighten you more on the subject. If I can be of any further assistance please to not hesitate to ask. Best wishes.

 

Emmanuel Asante

 

<>

 

____________________________________

 

Dr. Emmanuel A Asante MRC Prion Unit & Neurogenetics Dept. Imperial College School of Medicine (St. Mary's) Norfolk Place, LONDON W2 1PG Tel: +44 (0)20 7594 3794 Fax: +44 (0)20 7706 3272 email: e.asante@ic.ac.uk (until 9/12/02) New e-mail: e.asante@prion.ucl.ac.uk (active from now)

 

____________________________________

 


 

Wednesday, October 09, 2013

 

WHY THE UKBSEnvCJD ONLY THEORY IS SO POPULAR IN IT'S FALLACY, £41,078,281 in compensation REVISED

 


 

U.S.A. 50 STATE BSE MAD COW CONFERENCE CALL Jan. 9, 2001

 


 

Saturday, April 19, 2014

 

Exploring the zoonotic potential of animal prion diseases: In vivo and in vitro approaches

 


 

TSS

Monday, February 10, 2014

Enhanced Virulence of Sheep-Passaged Bovine Spongiform Encephalopathy Agent Is Revealed by Decreased Polymorphism Barriers in Prion Protein Conversion Studies

Enhanced Virulence of Sheep-Passaged Bovine Spongiform Encephalopathy Agent Is Revealed by Decreased Polymorphism Barriers in Prion Protein Conversion Studies

 

Jan Priema, Jan P. M. Langevelda, Lucien J. M. van Keulena, Fred G. van Zijderveldb, Olivier Andreolettic and Alex Bossersa

 

+ Author Affiliations aDepartment of Infection Biology, Central Veterinary Institute of Wageningen UR, Lelystad, The Netherlands bDepartment of Bacteriology and TSEs, Central Veterinary Institute of Wageningen UR, Lelystad, The Netherlands cUMR INRA ENVT 1225, Interactions Hôtes Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, France

 

ABSTRACT

 

Bovine spongiform encephalopathy (BSE) can be efficiently transmitted to small ruminants (sheep and goats) with certain prion protein (PrP) genotypes. Polymorphisms in PrP of both the host and donor influence the transmission efficiency of transmissible spongiform encephalopathies (TSEs) in general. These polymorphisms in PrP also modulate the PrP conversion underlying TSE agent replication. Here we demonstrate that single-round protein misfolding cyclic amplification (PMCA) can be used to assess species and polymorphism barriers at the molecular level. We assessed those within and between the ovine and bovine species in vitro using a variety of natural scrapie and experimentally generated cross-species BSE agents. These BSE agents include ovBSE-ARQ isolates (BSE derived from sheep having the ARQ/ARQ PrP genotype), and two unique BSE-derived variants: BSE passaged in VRQ/VRQ sheep and a cow BSE agent isolate generated by back-transmission of ovBSE-ARQ into its original host. PMCA allowed us to quantitatively determine PrP conversion profiles that correlated with known in vivo transmissibility and susceptibility in the two ruminant species in which strain-specific molecular signatures, like its molecular weight after protease digestion, were maintained. Furthermore, both BSE agent isolates from ARQ and VRQ sheep demonstrated a surprising transmission profile in which efficient transmissions to both sheep and bovine variants was combined. Finally, all data support the notion that ARQ-derived sheep BSE points to a significant increase in virulence compared to all other tested scrapie- and BSE-derived variants reflected by the increased conversion efficiencies of previously inefficient convertible PrP variants (including the so-called “resistant” sheep ARR variant).

 

IMPORTANCE Prion diseases such as scrapie in sheep and goats, BSE in cattle, and Creutzfeldt-Jakob disease (CJD) in humans are fatal neurodegenerative diseases caused by prions. BSE is known to be transmissible to a variety of hosts, including sheep and humans. Based on the typical BSE agent strain signatures and epidemiological data, the occurrence of a novel variant of CJD in humans was linked to BSE occurrence in the United Kingdom. Measures, including genetic selection of sheep toward less susceptible PrP genotypes, have been implemented to lower the risk of BSE transmission into sheep, since the disease could potentially spread into a natural reservoir. In this study, we demonstrated using molecular PrP conversion studies that when BSE is first transmitted through sheep, the host range is modified significantly and the PrP converting potency increased, allowing the ovine BSE to transmit more efficiently than cow BSE into supposedly less susceptible hosts.

 

 FOOTNOTES Received 25 August 2013. Accepted 19 December 2013. Address correspondence to Alex Bossers, alex.bossers@wur.nl.

 

Published ahead of print 26 December 2013

 

Copyright © 2014, American Society for Microbiology. All Rights Reserved.

 

 


 

 

Thursday, December 05, 2013

 

National Scrapie Eradication Program October 2013 Monthly Report Fiscal Year 2014 TSE PRION REPORT

 


 

 

Sunday, November 17, 2013

 

L-BSE in Genetically Susceptible and Resistant Sheep: Changes in Prion Strain or Phenotypic Plasticity of the Disease-Associated Prion Protein?

 


 

 

Saturday, November 02, 2013

 

OREGON DETECTS SCRAPIE

 


 

 

Friday, July 26, 2013

 

Voluntary Scrapie Program USA UPDATE July 26, 2013 increase in FY 2013 is not statistically meaningful due to the sample size

 

Greetings BSE-L members et al,

 

“The increase in FY 2013 is not statistically meaningful due to the sample size.”

 

SO, when a TSE mad cow type disease is NOT detectable with a surveillance system that is set up to test numbers so low you can’t find it, and you complain on that one factor, then USDA inc tells you that those are the number set up by OIE inc, and are sufficient to find a TSE mad cow type disease in said species, and that’s good enough for them, as far as ‘sample size’.

 

BUT yet, when the shoe is on the other foot so to speak, oh well, it’s a different story now, the increase in Scrapie cases for the FY 2013 is NOT meaningful now due to the sample size.

 

yep, that’s what happened out in the Trans Pecos region where I told the TAHC et al to test for CWD ten years ago, I complained about that sample size being totally insufficient, where I knew the CWD positives were waltzing into Texas, well, they let these CWD positives do it for another 10 years before doing anything about it, and when they finally increased the sample size, guess what, they found CWD in TEXAS.

 

same thing happened with mad cow disease. they increased the sample size, found it, scared the hell out of them because of all the atypicals, and immediately shut it down, back to OIE numbers, where you cannot find a TSE prion disease. what a bunch of hypocrites, and what a joke. all of them.

 

I suppose the high number of goat cases in California and Michigan, and the two meat-type twin goats residing in the same herd that tested positive, both that were submitted as clinical suspects, I guess that’s just another happenstance of bad luck, another spontaneous event, ...really?

 

*** I have been trying to bring awareness to the increase in numbers of goat scrapie cases in certain areas for years now from different potential sources, to no avail. how many of them might be BSE? as the USDA inc, the OIE inc, CFIA inc, all try to make typical scrapie a legal trading commodity (they have already done this with the atypical scrapie, a very foolish move, one that risk both humans and animals around the globe to the TSE mad cow type agent). this voluntary scrapie program will not work, in my opinion, the USDA, OIE, CFIA, know this, so the next best thing is just to force feed all of us around the globe the TSE prion mad cow type agent by exempting it all $$$ it’s all gonna catch up sooner or later. just my take. ...

 

Friday, July 26, 2013

 

Voluntary Scrapie Program USA UPDATE July 26, 2013 increase in FY 2013 is not statistically meaningful due to the sample size http://scrapie-usa.blogspot.com/2013/07/voluntary-scrapie-program-usa-update.html

 

Sunday, June 2, 2013

 

Characterisation of an Unusual TSE in a Goat by Transmission in Knock-in Transgenic Mice

 


 

 

 Saturday, July 6, 2013

 

*** Small Ruminant Nor98 Prions Share Biochemical Features with Human Gerstmann-Sträussler-Scheinker Disease and Variably Protease-Sensitive Prionopathy

 

Research Article

 


 

 

Thursday, March 29, 2012

 

atypical Nor-98 Scrapie has spread from coast to coast in the USA 2012

 

NIAA Annual Conference April 11-14, 2011San Antonio, Texas

 


 

 

Wednesday, January 18, 2012

 

BSE IN GOATS CAN BE MISTAKEN FOR SCRAPIE

 

February 1, 2012

 


 

 

Wednesday, January 18, 2012

 

Selection of Distinct Strain Phenotypes in Mice Infected by Ovine Natural Scrapie Isolates Similar to CH1641 Experimental Scrapie

 

Journal of Neuropathology & Experimental Neurology:

 

February 2012 - Volume 71 - Issue 2 - p 140–147

 


 

 

Thursday, July 14, 2011

 

Histopathological Studies of "CH1641-Like" Scrapie Sources Versus Classical Scrapie and BSE Transmitted to Ovine Transgenic Mice (TgOvPrP4)

 


 

 

SHEEP AND BSE

 

PERSONAL AND CONFIDENTIAL

 

SHEEP AND BSE

 

A. The experimental transmission of BSE to sheep.

 

Studies have shown that the ''negative'' line NPU flock of Cheviots can be experimentally infected with BSE by intracerebral (ic) or oral challenge (the latter being equivalent to 0.5 gram of a pool of four cow brains from animals confirmed to have BSE).

 


 

 

RB264

 

BSE - TRANSMISSION STUDIES

 


 

 

Wednesday, January 18, 2012

 

Selection of Distinct Strain Phenotypes in Mice Infected by Ovine Natural Scrapie Isolates Similar to CH1641 Experimental Scrapie

 

Journal of Neuropathology & Experimental Neurology:

 

February 2012 - Volume 71 - Issue 2 - p 140–147

 


 

 

Saturday, December 3, 2011

 

Isolation of Prion with BSE Properties from Farmed Goat Volume 17, Number 12—December 2011

 


 

 

Wednesday, February 16, 2011

 

IN CONFIDENCE SCRAPIE TRANSMISSION TO CHIMPANZEES IN CONFIDENCE

 


 

 

Sunday, December 12, 2010

 

EFSA reviews BSE/TSE infectivity in small ruminant tissues News Story 2 December 2010

 


 

 

Sunday, April 18, 2010

 

SCRAPIE AND ATYPICAL SCRAPIE TRANSMISSION STUDIES A REVIEW 2010

 


 

 
Sunday, February 2, 2014
 
The Presence of Disease-Associated Prion Protein in Skeletal Muscle of Cattle Infected with Classical Bovine Spongiform Encephalopathy
 
NOTE Pathology
 
 
 
 
 

 

TSS

Monday, February 3, 2014

Evaluation of the zoonotic potential of transmissible mink encephalopathy TSE Prion disease


Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES



Title: Evaluation of the zoonotic potential of transmissible mink
 encephalopathy


Authors



item Comoy, Emmanuel - item Mikol, Jacqueline - item Ruchoux, Marie-Madeleine - item Durand, Valerie - item Luccantoni-Freire, Sophie - item Dehen, Capucine - item Correia, Evelyne - item Casalone, Cristina - item Richt, Juergen item Greenlee, Justin item Torres, Juan Maria - item Brown, Paul - item Deslys, Jean-Philippe -



Submitted to: Pathogens Publication Type: Peer Reviewed Journal Publication Acceptance Date: July 30, 2013 Publication Date: July 30, 2013 Citation: Comoy, E.E., Mikol, J., Ruchoux, M., Durand, V., Luccantoni-Freire, S., Dehen, C., Correia, E., Casalone, C., Richt, J.A., Greenlee, J.J., Torres, J.M., Brown, P., Deslys, J. 2013. Evaluation of the zoonotic potential of transmissible mink encephalopathy. Pathogens. 2:(3)520-532.



Interpretive Summary: Cases of bovine spongiform encephalopathy (BSE) or mad cow disease can be subclassified into at least 3 distinct disease forms with the predominate form known as classical BSE and the others collectively referred to as atypical BSE. Atypical BSE can be further subdivided into H-type and  L-type cases that are distinct from classical BSE and from each other. Both of the atypical BSE subtypes are believed to occur spontaneously, whereas classical BSE is spread through feeding contaminated meat and bone meal to cattle. Transmissible mink encephalopathy (TME) is another prion disease that transmits to cattle and show similarities to L-type BSE when subjected to laboratory testing. The purpose of this study was to use non-human primates (cynomologous macaque) and transgenic mice expressing the human prion protein to determine if TME could represent a potential risk to human health. TME from two sources (cattle and raccoons) was able to infect non-human primates and transgenic mice after exposure by the intracranial route. This result suggest that humans may be able to replicate TME prions after an exposure that allows infectious material access to brain tissue. At this time, it is unknown whether non-human primates or transgenic mice would be susceptible to TME prions after oral exposure. The results obtained in these animal models were similar to those obtained for L-type BSE. Although rare, the existence of TME and that it transmits to cattle, non-human primates, and transgenic mice suggest that feed bans preventing the feeding of mammalian tissues to cattle should stay in place and that regular prion surveillance during the slaughter should remain in place. Parties with  interest in the cattle and beef industries and regulatory officials responsible for safe feeding practices of cattle will be interested in this work. Technical Abstract: Successful transmission of Transmissible Mink Encephalopathy (TME) to cattle supports the bovine hypothesis to the still controversial origin of TME outbreaks. Human and primate susceptibility to classical Bovine Spongiform Encephalopathy (c-BSE) and the transmissibility of L-type BSE to macaques assume a low cattle-to-primate species barrier: we therefore evaluated the zoonotic potential of cattle-adapted TME. In less than two years, this strain induced in cynomolgus macaques a neurological disease similar to L-BSE and distinct from c-BSE. TME derived from another donor species (raccoon) induced a similar disease with shorter incubation periods. L-BSE and cattle-adapted TME were also transmissible to transgenic mice expressing human PrP. Interestingly, secondary transmissions to transgenic mice expressing bovine PrP showed the maintenance of prion strain features for the three tested bovine prion strains (cattle TME, c-BSE and L-BSE) regardless of intermediate host. Thus, TME is the third animal prion strain transmissible to both macaques and humanized transgenic mice, suggesting zoonotic potentials that should be considered in the risk analysis of animal prion diseases for human health. Moreover, the similarities between TME and L-BSE are highly suggestive of a link between those strains, and of the presence of L-BSE decades prior to its identification in USA and Europe.



http://www.ars.usda.gov/research/publications/publications.htm?seq_no_115=293985





Research Project: Transmission, Differentiation, and Pathobiology of Transmissible Spongiform Encephalopathies Project Number: 3625-32000-103-00 Project Type: Appropriated



Start Date: Oct 01, 2011 End Date: Sep 30, 2016



Objective: 1. Investigate the pathobiology of atypical transmissible spongiform encephalopathies (TSEs) in natural hosts. A. Investigate the pathobiology of atypical scrapie. B. Investigate the pathobiology of atypical bovine spongiform encephalopathy (BSE). 2. Investigate the horizontal transmission of TSEs. A. Assess the horizontal transmission of sheep scrapie in the absence of lambing. B. Determine routes of transmission in chronic wasting disease (CWD) infected premises. C. Assess oral transmission of CWD in reindeer. 3. Investigate determinants of CWD persistence. A. Determine CWD host range using natural routes of transmission. B. Investigate the pathobiology of CWD.



Approach: The studies will focus on three animal transmissible spongiform encephalopathy (TSE) agents found in the United States: bovine spongiform encephalopathy (BSE); scrapie of sheep and goats; and chronic wasting disease (CWD) of deer, elk, and moose. The research will address sites of accumulation, routes of infection, environmental persistence, and ante mortem diagnostics with an emphasis on controlled conditions and natural routes of infection. Techniques used will include clinical exams, histopathology, immunohistochemistry and biochemical analysis of proteins. The enhanced knowledge gained from this work will help mitigate the potential for unrecognized epidemic expansions of these diseases in populations of animals that could either directly or indirectly affect food animals.



 http://www.ars.usda.gov/research/projects/projects.htm?ACCN_NO=421870



Thursday, August 12, 2010



Seven main threats for the future linked to prions



First threat



The TSE road map defining the evolution of European policy for protection against prion diseases is based on a certain numbers of hypotheses some of which may turn out to be erroneous. In particular, a form of BSE (called atypical Bovine Spongiform Encephalopathy), recently identified by systematic testing in aged cattle without clinical signs, may be the origin of classical BSE and thus potentially constitute a reservoir, which may be impossible to eradicate if a sporadic origin is confirmed. ***Also, a link is suspected between atypical BSE and some apparently sporadic cases of Creutzfeldt-Jakob disease in humans. These atypical BSE cases constitute an unforeseen first threat that could sharply modify the European approach to prion diseases.



Second threat



snip...



http://www.neuroprion.org/en/np-neuroprion.html



EFSA Journal 2011 The European Response to BSE: A Success Story



This is an interesting editorial about the Mad Cow Disease debacle, and it's ramifications that will continue to play out for decades to come ;



Monday, October 10, 2011



EFSA Journal 2011 The European Response to BSE: A Success Story



snip...



EFSA and the European Centre for Disease Prevention and Control (ECDC) recently delivered a scientific opinion on any possible epidemiological or molecular association between TSEs in animals and humans (EFSA Panel on Biological Hazards (BIOHAZ) and ECDC, 2011). This opinion confirmed Classical BSE prions as the only TSE agents demonstrated to be zoonotic so far but the possibility that a small proportion of human cases so far classified as "sporadic" CJD are of zoonotic origin could not be excluded. Moreover, transmission experiments to non-human primates suggest that some TSE agents in addition to Classical BSE prions in cattle (namely L-type Atypical BSE, Classical BSE in sheep, transmissible mink encephalopathy (TME) and chronic wasting disease (CWD) agents) might have zoonotic potential.



snip...



http://www.efsa.europa.eu/en/efsajournal/pub/e991.htm?emt=1



http://www.efsa.europa.eu/en/efsajournal/doc/e991.pdf



see follow-up here about North America BSE Mad Cow TSE prion risk factors, and the ever emerging strains of Transmissible Spongiform Encephalopathy in many species here in the USA, including humans ;



http://transmissiblespongiformencephalopathy.blogspot.com/2011/10/efsa-journal-2011-european-response-to.html



*** 2010-2011 ***



When L-type BSE was inoculated into ovine transgenic mice and Syrian hamster the resulting molecular fingerprint had changed, either in the first or a subsequent passage, from L-type into C-type BSE. In addition, non-human primates are specifically susceptible for atypical BSE as demonstrated by an approximately 50% shortened incubation time for L-type BSE as compared to C-type. Considering the current scientific information available, it cannot be assumed that these different BSE types pose the same human health risks as C-type BSE or that these risks are mitigated by the same protective measures.



This study will contribute to a correct definition of specified risk material (SRM) in atypical BSE. The incumbent of this position will develop new and transfer existing, ultra-sensitive methods for the detection of atypical BSE in tissue of experimentally infected cattle.



http://www.prionetcanada.ca/detail.aspx?menu=5&dt=293380&app=93&cat1=387&tp=20&lk=no&cat2



Monday, September 26, 2011 L-BSE BASE prion and atypical sporadic CJD



Risk.12:



Transmission of Atypical Italian sCJD Case to Humanized Mice Reveals a Novel Infectious Strain



Roberta Galeno,1,† Marco Sbriccoli,1 Loredana Ingrosso,1 Silvia Graziano,1 Angelina Valanzano,1 Anna Poleggi,1 Angela De Pascalis,1 Anna Ladogana,1 Franco Cardone,1 Maria Puopolo,1 Gianluigi Zanusso2 and Maurizio Pocchiari1



1Istituto Superiore di Sanità; Rome, Italy; 2University of Verona; Verona, Italy†Presenting author; Email: roberta.galeno@iss.it



Sporadic Creutzfeldt-Jakob disease (sCJD) is a neurodegenerative prion disorder with uncertain etiology characterized by a typical combination of clinical symptoms, neuropathological lesions, and by the deposition of the pathological protein PrPTSE in the brain.



The vast majority of patients affected by sCJD can be categorized according to the genotype at the polymorphic position www.landesbioscience.com Prion 127



129 of PrP (methionine or valine) and to the molecular mass of PrPTSE (type 1 or 2, corresponding to 21 or 19 kDa), yielding six possible combinations (MM1, MM2, VV1, VV2, MV1, and MV2) that associate with five clinico-pathological variants. Transmission studies of these sCJD subtypes into transgenic mice expressing the human prion protein allowed to identify four different infectious strains, which can partly explain the heterogeneity observed in sCJD patients.1



We recently described a novel molecular and pathological phenotype of sCJD (MV at position 129 of PrP), associated with an unprecedented electrophoretic pattern of PrPTSE characterized by the absence of the highly glycosylated isoform. In this work, we sought to characterize the prion strain associated with this atypical case by intracerebral inoculation into gene-targeted transgenic mice (HuTg) carrying the human PRNP gene with the three 129 genotype combinations. For comparison, three Italian sCJD cases heterozygous at position 129 of the prion protein, belonging to different subtypes (MV1, MV1/2, MV2), were transmitted to the same panel of transgenic mice. Survival times, attack rates, lesion profiles, and molecular analysis of the PrPTSE type recovered from mouse brains injected with the atypical case were compared with data from control animals. Mice inoculated with the atypical case displayed a restricted host tropism, with only a small number of VV animals that resulted PrPTSE-positive after an exceedingly long survival time. Interestingly, PrPTSE accumulated in brains from these mice lacks the diglycosylated band similar to that in sCJD inoculum, yet dissimilar to any other PrPTSE observed in HuTg mice by us and by other authors.1,2 Overall, these results strongly indicate that our atypical case associates with a new infectious strain of sCJD. Further investigations are needed to understand the possible connection with other human and animal prion diseases.



References



1. Bishop MT, Will RG, Manson JC. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 2010; 107:12005-10.



2. Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, Thomson V, et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 2006; 5:393-8.



http://www.prion2011.ca/files/PRION_2011_-_Posters_(May_5-11).pdf



Saturday, June 25, 2011



Transmissibility of BSE-L and Cattle-Adapted TME Prion Strain to Cynomolgus Macaque



"BSE-L in North America may have existed for decades"



http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/transmissibility-of-bse-l-and-cattle.html



Sunday, June 26, 2011



Risk Analysis of Low-Dose Prion Exposures in Cynomolgus Macaque



http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/risk-analysis-of-low-dose-prion.html



2011 Monday, September 26, 2011



L-BSE BASE prion and atypical sporadic CJD



http://bse-atypical.blogspot.com/2011/09/l-bse-base-prion-and-atypical-sporadic.html



Sunday, February 2, 2014



The Presence of Disease-Associated Prion Protein in Skeletal Muscle of Cattle Infected with Classical Bovine Spongiform Encephalopathy



NOTE Pathology



http://bovineprp.blogspot.com/2014/02/the-presence-of-disease-associated.html



WHAT about the sporadic CJD TSE proteins ?



WE now know that some cases of sporadic CJD are linked to atypical BSE and atypical Scrapie, so why are not MORE concerned about the sporadic CJD, and all it’s sub-types $$$



Creutzfeldt-Jakob Disease CJD cases rising North America updated report August 2013



*** Creutzfeldt-Jakob Disease CJD cases rising North America with Canada seeing an extreme increase of 48% between 2008 and 2010 ***



http://creutzfeldt-jakob-disease.blogspot.com/2013/08/creutzfeldt-jakob-disease-cjd-cases.html



Sunday, October 13, 2013



*** CJD TSE Prion Disease Cases in Texas by Year, 2003-2012



http://creutzfeldt-jakob-disease.blogspot.com/2013/10/cjd-tse-prion-disease-cases-in-texas-by.html



Thursday, January 2, 2014



*** CWD TSE Prion in cervids to hTGmice, Heidenhain Variant Creutzfeldt-Jacob Disease MM1 genotype, and iatrogenic CJD ???



http://transmissiblespongiformencephalopathy.blogspot.com/2014/01/cwd-tse-prion-in-cervids-to-htgmice.html



Friday, January 10, 2014



*** vpspr, sgss, sffi, TSE, an iatrogenic by-product of gss, ffi, familial  type prion disease, what it ???



http://transmissiblespongiformencephalopathy.blogspot.com/2014/01/vpspr-sgss-sffi-tse-iatrogenic-by.html



Monday, January 13, 2014



*** Prions in Variably Protease-Sensitive Prionopathy: An Update Pathogens 2013



Pathogens 2013, 2, 457-471; doi:10.3390/pathogens2030457



http://prionopathy.blogspot.com/2014/01/prions-in-variably-protease-sensitive.html



Wednesday, January 15, 2014



*** INFECTION PREVENTION AND CONTROL OF CJD, VCJD AND OTHER HUMAN PRION DISEASES IN HEALTHCARE AND COMMUNITY SETTINGS Variably Protease-Sensitive  Prionopathy (VPSPr) January 15, 2014



http://transmissiblespongiformencephalopathy.blogspot.com/2014/01/infection-prevention-and-control-of-cjd.html



Sunday, January 19, 2014



*** National Prion Disease Pathology Surveillance Center Cases Examined1 as of January 8, 2014 ***



http://prionunitusaupdate.blogspot.com/2014/01/national-prion-disease-pathology.html



Thursday, January 23, 2014



Medical Devices Containing Materials Derived from Animal Sources (Except for In Vitro Diagnostic Devices) [Docket No. FDA–2013–D–1574]



http://transmissiblespongiformencephalopathy.blogspot.com/2014/01/medical-devices-containing-materials.html



Saturday, February 01, 2014



vCJD With Extremely Low Lymphoreticular Deposition of Prion Protein MAY NOT HAVE BEEN DETECTABLE



http://vcjd.blogspot.com/2014/02/vcjd-with-extremely-low-lymphoreticular.html



Wednesday, April 24, 2013



Chimpanzees Released After 30 Years Of Testing, Brace Yourself For Smiles



i remember the late great Dr. Gibbs at NIH whom studied transmissible spongiform encephalopathy prion disease his whole life, and was a great scientist, i remember him saying how bad he hated using chimps for research. he grew very close to the chimps, and it disturbed him greatly. i always thought we should use humans instead of chimps. i.e. death row inmates. expose them, study them, compensate their families. this would indeed put to end the controversy and excuse of 'oh, chimps are not humans, study does not hold water' type mentality. of course it would be a voluntary program.



see this moving video here ;



http://transmissiblespongiformencephalopathy.blogspot.com/2013/04/chimpanzees-released-after-30-years-of.html



Wednesday, January 01, 2014



Molecular Barriers to Zoonotic Transmission of Prions



*** chronic wasting disease, there was no absolute barrier to conversion of the human prion protein.



*** Furthermore, the form of human PrPres produced in this in vitro assay when seeded with CWD, resembles that found in the most common human prion disease, namely sCJD of the MM1 subtype.



http://wwwnc.cdc.gov/eid/article/20/1/13-0858_article.htm



http://chronic-wasting-disease.blogspot.com/2014/01/molecular-barriers-to-zoonotic.html




UPDATED CORRESPONDENCE FROM AUTHORS OF THIS STUDY I.E. COLBY, PRUSINER ET AL, ABOUT MY CONCERNS OF THE DISCREPANCY BETWEEN THEIR FIGURES AND MY FIGURES OF THE STUDIES ON CWD TRANSMISSION TO CATTLE ;



----- Original Message -----



From: David Colby



To: flounder9@verizon.net



Cc: stanley@XXXXXXXX



Sent: Tuesday, March 01, 2011 8:25 AM



Subject: Re: FW: re-Prions David W. Colby1,* and Stanley B. Prusiner1,2 + Author Affiliations



Dear Terry Singeltary,



Thank you for your correspondence regarding the review article Stanley Prusiner and I recently wrote for Cold Spring Harbor Perspectives. Dr. Prusiner asked that I reply to your message due to his busy schedule. We agree that the transmission of CWD prions to beef livestock would be a troubling development and assessing that risk is important. In our article, we cite a peer-reviewed publication reporting confirmed cases of laboratory transmission based on stringent criteria. The less stringent criteria for transmission described in the abstract you refer to lead to the discrepancy between your numbers and ours and thus the interpretation of the transmission rate. We stand by our assessment of the literature--namely that the transmission rate of CWD to bovines appears relatively low, but we recognize that even a low transmission rate could have important implications for public health and we thank you for bringing attention to this matter.



Warm Regards, David Colby



--



David Colby, PhDAssistant ProfessorDepartment of Chemical EngineeringUniversity of Delaware



====================END...TSS==============



SNIP...SEE FULL TEXT ;



http://betaamyloidcjd.blogspot.com/2011/01/enlarging-spectrum-of-prion-like.html







UPDATED DATA ON 2ND CWD STRAIN



Wednesday, September 08, 2010



CWD PRION CONGRESS SEPTEMBER 8-11 2010



http://chronic-wasting-disease.blogspot.com/2010/09/cwd-prion-2010.html




Thursday, November 21, 2013



Assessing the susceptibility of transgenic mice over-expressing deer prion protein to bovine spongiform encephalopathy



http://chronic-wasting-disease.blogspot.com/2013/11/assessing-susceptibility-of-transgenic.html



KURU



*** These findings are consistent with the hypothesis that kuru originated from chance consumption of an individual with sporadic CJD.



Kuru prions and sporadic Creutzfeldt–Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice



Jonathan D. F. Wadsworth, Susan Joiner, Jacqueline M. Linehan, Melanie Desbruslais, Katie Fox, Sharon Cooper, Sabrina Cronier, Emmanuel A. Asante, Simon Mead, Sebastian Brandner, Andrew F. Hill *, and John Collinge † Author Affiliations



Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, United Kingdom Communicated by Charles Weissmann, The Scripps Research Institute, Jupiter, FL, January 10, 2008 (received for review October 10, 2007)



Abstract Kuru provides our principal experience of an epidemic human prion disease and primarily affected the Fore linguistic group of the Eastern Highlands of Papua New Guinea. Kuru was transmitted by the practice of consuming dead relatives as a mark of respect and mourning (transumption). To date, detailed information of the prion strain type propagated in kuru has been lacking. Here, we directly compare the transmission properties of kuru prions with sporadic, iatrogenic, and variant Creutzfeldt–Jakob disease (CJD) prions in Prnp-null transgenic mice expressing human prion protein and in wild-type mice. Molecular and neuropathological data from these transmissions show that kuru prions are distinct from variant CJD and have transmission properties equivalent to those of classical (sporadic) CJD prions.



*** These findings are consistent with the hypothesis that kuru originated from chance consumption of an individual with sporadic CJD.



http://www.pnas.org/content/105/10/3885



1: J Infect Dis 1980 Aug;142(2):205-8



Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates.



Gibbs CJ Jr, Amyx HL, Bacote A, Masters CL, Gajdusek DC.



Kuru and Creutzfeldt-Jakob disease of humans and scrapie disease of sheep and goats were transmitted to squirrel monkeys (Saimiri sciureus) that were exposed to the infectious agents only by their nonforced consumption of known infectious tissues. The asymptomatic incubation period in the one monkey exposed to the virus of kuru was 36 months; that in the two monkeys exposed to the virus of Creutzfeldt-Jakob disease was 23 and 27 months, respectively; and that in the two monkeys exposed to the virus of scrapie was 25 and 32 months, respectively. Careful physical examination of the buccal cavities of all of the monkeys failed to reveal signs or oral lesions. One additional monkey similarly exposed to kuru has remained asymptomatic during the 39 months that it has been under observation.



snip...



The successful transmission of kuru, Creutzfeldt-Jakob disease, and scrapie by natural feeding to squirrel monkeys that we have reported provides further grounds for concern that scrapie-infected meat may occasionally give rise in humans to Creutzfeldt-Jakob disease.



PMID: 6997404



http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6997404&dopt=Abstract



Wednesday, November 18, 2009



A Novel Protective Prion Protein Variant that Colocalizes with Kuru Exposure



http://kuru-tse.blogspot.com/2009/11/novel-protective-prion-protein-variant.html



http://kuru-tse.blogspot.com/




Sunday, September 1, 2013



 Evaluation of the Zoonotic Potential of Transmissible Mink Encephalopathy



http://transmissiblespongiformencephalopathy.blogspot.com/2013/09/evaluation-of-zoonotic-potential-of.html





Sunday, February 2, 2014



The Presence of Disease-Associated Prion Protein in Skeletal Muscle of Cattle Infected with Classical Bovine Spongiform Encephalopathy



NOTE Pathology



http://bovineprp.blogspot.com/2014/02/the-presence-of-disease-associated.html









Terry S. Singeltary Sr. Bacliff, Texas USA 77518 flounder9@verizon.net